U.S. markets open in 9 hours 29 minutes

Exscientia plc (0RK.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
6.40-0.10 (-1.54%)
At close: 04:53PM CET

Exscientia plc

The SchrOedinger Building
Oxford Science Park
Oxford OX4 4GE
United Kingdom
44 18 6581 8941

Full Time Employees481

Key Executives

NameTitlePayExercisedYear Born
Dr. David Hallett Ph.D.Chief Scientific Officer, Interim CEO, Principal Executive Officer & Executive DirectorN/AN/A1971
Mr. Ben R. TaylorCFO, Chief Strategy Officer & Executive Director445.7kN/A1977
Dr. Michael Krams M.D.Chief Quantitative Medicine OfficerN/AN/A1961
Ms. Eileen Jennings-BrownChief Information OfficerN/AN/AN/A
Ms. Sara ShermanVice President of Investor RelationsN/AN/AN/A
Mr. Dan IrelandVice President of Legal & Company SecretaryN/AN/AN/A
Mr. Parker MossExecutive Vice President of Corporate DevelopmentN/AN/AN/A
Ms. Caroline RowlandChief People OfficerN/AN/AN/A
Mr. Richard LawChief Business OfficerN/AN/AN/A
Dr. John P. Overington Ph.D.Chief Data OfficerN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. It also focuses on discovery and development of small molecule drug candidates. The company's platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. Exscientia plc was founded in 2012 and is headquartered in Oxford, the United Kingdom.

Corporate Governance

Exscientia plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.